Molecular Profiling of Diffuse Large B Cell Lymphoma and Acute Leukemias Treated with Dose Intense Regimens Read more
Outcomes of Anti-CD19 Chimeric Antigen Receptor (CAR) T-cell Patients: Real World Experience in Lymphoma Patients Read more
Outcomes and Prognostic Factors of patients diagnosed with high-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study Read more
Clinical Efficacy and Mechanisms of Resistance to Polatuzumab Vedotin in Patients with Large B-cell Lymphoma After CAR T-cell therapy Read more
Outcomes of patients with aggressive B-cell non-Hodgkin s lymphoma who undergo hematopoietic cell transplantation after CAR T-cell therapy Read more
Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): A Phase II Study with Safety Lead-in Read more
Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations and Risk of Subsequent Myeloid Malignancies in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant (ASCT) Read more
